This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Inoue, T. Articles by Morooka, S. Search for Related Content PubMed PubMed Citation Articles by Inoue, T. Articles by Morooka, S.

Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease

^a Department of Cardiology, Koshigaya Hospital, Dokkyo University School of Medicine, Koshigaya, Saitama, Japan

View larger version (21K): [in a new window]   Figure 1 Comparison of anti-Ox-LDL titer among the patient groups of control, single-vessel CAD and multivessel CAD. The titer was higher in the multivessel CAD group than in controls. No significant difference was seen between the single-vessel CAD group and the controls, or between the multivessel CAD group and the single-vessel CAD group. Anti-Ox-LDL = antibodies against oxidized low density lipoprotein; CAD = coronary artery disease; NS = not significant.

View larger version (19K): [in a new window]   Figure 2 Comparison of anti-Ox-LDL titer among the patients with stable-effort angina or OMI, unstable angina, and AMI. The titer was higher in patients with unstable angina or AMI than in patients with stable-effort angina or OMI. AMI = acute myocardial infarction; anti-Ox-LDL = antibodies against oxidized low density lipoprotein; AP = angina pectoris; OMI = old myocardial infarction.